Gas Exchange

Overview of Gas Exchange and Physiology

• Definition of Gas Exchange: The essential physiological process by which oxygen ($O_2$) is transported to tissue cells and carbon dioxide ($CO_2$) is transported from cells out of the body.

• Neural and Chemical Regulation: Neural and chemical regulators control the respiratory rate and depth of ventilation in response to fluctuating tissue oxygen demands and metabolic changes.

• Cardiovascular Transport System: The cardiovascular system provides the essential pump and circulatory network to distribute oxygenated blood to tissues and transport carbon dioxide waste back to the lungs.

Case Study: Clinical Progress and Management of Mr. Daniels

• Patient Profile and Initial Admission:

  • Patient Details: Mr. Daniels, a 68-year-old male admitted with a diagnosis of pneumonia.

  • Baseline Physical Assessment: Respiratory rate ($RR$) of $22\,\text{breaths/min}$, Heart rate ($HR$) of $102\,\text{bpm}$, Blood pressure ($BP$) of $134/78\,\text{mmHg}$, Oxygen saturation ($SpO_2$) of $91\%$ on room air, and Temperature of $101.2^\circ\text{F}$.

  • Respiratory Findings: Productive cough yielding yellow sputum, with audible crackles bilaterally in the lower lung lobes.

• Initial Provider Orders:

  • Supplemental oxygen via nasal cannula at $2\,\text{L/min}$.

  • Intravenous (IV) antibiotic therapy.

  • Incentive spirometer usage ($10\,\text{times/hour}$).

• Reassessment at 2 Hours:

  • Clinical Findings: $SpO_2$ increases to $93\%$ on $2\,\text{L/min}$ nasal cannula, $RR$ increases to $24\,\text{breaths/min}$, and the patient reports fatigue.

  • Nursing Action: Monitor closely, encourage deep breathing and incentive spirometry, and assess for respiratory muscle exhaustion.

• Reassessment at 4 Hours (Early Hypoxia Signs):

  • Clinical Findings: $RR$ increases to $28\,\text{breaths/min}$, $HR$ increases to $118\,\text{bpm}$, $SpO_2$ drops to $88\%$ on $2\,\text{L/min}$, and the patient becomes visibly restless and anxious.

  • Physiological Interpretation: The patient is experiencing worsening hypoxemia and early respiratory distress; compensatory mechanisms (tachypnea, tachycardia) are failing to maintain adequate oxygenation.

• Clinical Deterioration Phase:

  • Clinical Findings: $SpO_2$ further declines to $86\%$, with increased work of breathing and visible use of intercostal and sternocleidomastoid accessory muscles.

  • Immediate Priority Action: Increase oxygen therapy per established standing protocols and immediately notify the primary healthcare provider.

• Acute Hypoventilation and Carbon Dioxide Retention Phase:

  • Clinical Findings: Patient suddenly becomes confused, $RR$ drops to $10\,\text{breaths/min}$ with shallow excursions, $SpO_2$ drops to $82\%$, and the patient is difficult to arouse.

  • Physiological Interpretation: The patient has transitioned from hyperventilatory compensation to severe hypoventilation and hypercapnic respiratory failure, retaining excessive $CO_2$ and suffering severe cerebral hypoxia.

• Final Emergency Status:

  • Clinical Findings: $RR$ decreases to $8\,\text{breaths/min}$, $SpO_2$ falls to $80\%$, and central cyanosis is present.

  • First Priority Action: Activate the Rapid Response Team immediately and apply high-flow oxygen via a non-rebreather mask.

Physiological Factors Affecting Oxygenation

• Decreased Oxygen-Carrying Capacity:

  • Anemia: Characterized by a deficiency in total red blood cells ($RBCs$) or structural hemoglobin ($Hgb$). Because hemoglobin is the primary transport protein for oxygen, low levels reduce the total blood oxygen content, causing tissue hypoxia despite normal arterial partial pressures of oxygen ($PaO_2$).

    • Clinical Manifestations: Pallor (especially face, conjunctiva, and nail beds), cold extremities, severe fatigue, muscular weakness, dizziness, lightheadedness, and dyspnea on exertion.

    • Onset: Develops slowly and insidiously over time.

  • Carbon Monoxide ($CO$) Poisoning: Carbon monoxide binds to hemoglobin with an affinity approximately $200\,\text{times}$ greater than that of oxygen, forming carboxyhemoglobin. This prevents oxygen from binding to hemoglobin and halts tissue delivery.

    • Common Causes: Enclosed spaces with faulty space heaters, running car engines in closed garages, gas stoves, and smoke inhalation during house fires.

    • Clinical Symptoms: Cephalea (headache—the earliest and most frequent symptom), dizziness, confusion, nausea, vomiting, dyspnea, weakness, fatigue, loss of consciousness, and classic cherry-red skin discoloration (a rare but pathognomonic late sign).

    • Pulse Oximetry Artifact: Pulse oximeters ($SpO_2$) cannot differentiate between oxyhemoglobin and carboxyhemoglobin, showing misleading readings of $100\%$ saturation despite lethal tissue hypoxia.

    • Treatment: Immediate removal to fresh air, administration of $100\%$ high-flow oxygen via a non-rebreather mask (which drastically reduces the elimination half-life of carbon monoxide), or hyperbaric oxygen chamber therapy.

    • Onset: Rapid and acute onset compared to anemia.

• Hypovolemia:

  • Mechanism: Severe reduction in intravascular circulating blood volume leads to peripheral hypoperfusion and impaired gas transport.

  • Etiologies: Hemorrhage, severe dehydration, fluid loss, or hypovolemic shock.

  • Delivery System Metaphor: Hypovolemia acts like a delivery system with fewer transport trucks; even if package supply (oxygen) is available, fewer trucks (blood volume) result in diminished delivery to tissue destinations.

  • Interventions: Fluid resuscitation with IV crystalloids or blood component transfusions to restore circulating volume.

• Decreased Inspired Oxygen Concentration:

  • Mechanism: A drop in ambient oxygen fraction ($FiO_2$) reduces alveolar partial pressure, decreasing oxygen diffusion into pulmonary capillaries.

  • Causes: High altitudes (where atmospheric pressure is lower), enclosed poorly ventilated spaces, upper or lower airway obstructions (choking, foreign body aspiration, severe acute asthma attacks, anaphylactic airway angioedema), and hypoventilation (e.g., opioid overdose from morphine, fentanyl, or heroin).

  • Filling Analogy: Attempting to fill water bottles from an almost empty stream—bottles (blood capacity) are adequate, but fluid source (ambient oxygen) is insufficient.

• Increased Metabolic Rate:

  • Mechanism: Elevated cellular metabolic processes increase cellular oxygen consumption ($VO_2$) beyond standard delivery capacities.

  • Conditions: Pregnancy (due to growing fetal and placental metabolic demands), active wound healing, high fever (body burns excess energy to fight infection, drastically raising oxygen demand), and physical exercise.

  • Crowd Metaphor: High demand creates a scenario where many individuals call an Uber simultaneously, but an insufficient number of cars leads to delayed transport.

• Conditions Affecting Chest Wall Movement:

  • Pregnancy: Enlarging uterus displaces abdominal viscera superiorly against the diaphragm, restricting downward thoracic expansion.

  • Obesity: Excessive adipose tissue surrounding the chest wall and abdomen increases thoracic load, causing low tidal volumes and shallow breathing.

  • Musculoskeletal Abnormalities: Structural chest deformities such as scoliosis, kyphosis, or traumatic rib fractures restrict thoracic compliance and expansion.

  • Trauma: Flail chest, rib fractures, or penetrating chest injuries induce severe pain and mechanical disruption, leading to voluntary splinting and hypoventilation.

  • Neuromuscular Diseases: Amyotrophic Lateral Sclerosis (ALS), Muscular Dystrophy, Guillain-Barré syndrome, or Myasthenia Gravis cause diaphragm and intercostal muscle weakness.

  • Central Nervous System (CNS) Alterations: Brainstem or cervical spinal cord trauma reduces neural respiratory drive signals.

  • Chronic Lung Diseases: Chronic Obstructive Pulmonary Disease (COPD) causes loss of elastic recoil, bronchial destruction, and air trapping.

  • Complication of Restricted Chest Movement: Inability to take deep breaths or cough effectively leads to secretion stasis, atelectasis, and a very high risk of secondary pneumonia.

Alterations in Respiratory Functioning

• Hypoventilation:

  • Definition: Inadequate alveolar ventilation to meet the body's metabolic oxygen demands or eliminate sufficient carbon dioxide.

  • Pathophysiology: Respiratory rate or tidal volume is excessively low, leading to arterial retention of carbon dioxide ($CO_2$) termed hypercapnia ($hypercapnic\,respiratory\,failure$), causing secondary hypoxemia.

  • Causes: Opioid/sedative/alcohol overdose, CNS depression, severe head injury, sleep apnea, rib fractures/pain, post-operative immobility, and respiratory muscle fatigue.

  • Signs & Symptoms: Slow, shallow respirations, morning headaches (from nocturnal $CO_2$ retention), somnolence, confusion, dysrhythmias, decreased $SpO_2$, elevated arterial $PaCO_2$, and eventual progression to uncorrected respiratory acidosis, convulsions, coma, and cardiac arrest.

  • COPD Hypoxic Drive:

    • In healthy individuals, hypercapnia (elevated $CO_2$) is the primary chemical stimulus to breathe.

    • In chronic COPD patients with persistent $CO_2$ retention, arterial chemoreceptors desensitize to hypercapnia, shifting the primary stimulus to breathe to low oxygen levels ($hypoxic\,drive$).

    • Clinical Caution: Administering high concentrations of unmonitored supplemental oxygen to COPD patients suppresses their hypoxic respiratory drive, precipitating severe hypoventilation, severe hypercapnia, respiratory failure, and death. Oxygen therapy must begin at the lowest effective dose (e.g., $1\text{--}2\,\text{L/min}$).

• Hyperventilation:

  • Definition: Excessive rate and depth of ventilation beyond cellular metabolic demands, eliminating carbon dioxide faster than it is produced.

  • Pathophysiology: Rapid $CO_2$ clearance produces hypocapnia, resulting in respiratory alkalosis (elevated blood $pH$).

  • Physiological Effects: Hypocapnia triggers cerebral vasoconstriction (causing reduced cerebral blood flow, lightheadedness, and dizziness) and transient hypocalcemia (causing carpopedal spasm, numbness, and tingling of extremities and perioral region).

  • Causes: Severe anxiety, panic attacks, high fever, intense pain, brainstem injuries, high altitude, pulmonary embolism, severe infection, and Diabetic Ketoacidosis (DKA).

  • Kussmaul's Respirations: Unique hyperventilatory pattern characterized by rapid, deep, labored respirations seen in DKA. The body attempts to compensate for metabolic ketoacidosis by exhaling large amounts of carbonic acid as $CO_2$. DKA patients frequently present with a characteristic sweet, fruity acetone breath odor.

  • Signs & Symptoms: Tachypnea, sighing respirations, lightheadedness, dizziness, syncope, perioral and peripheral paresthesias, chest tightness, palpitations, and feelings of terror/air hunger.

  • Nursing Interventions: Remain calm to lower patient anxiety, coach slow deep breaths, and utilize breathing into cupped hands or under supervised paper bag rebreathing to reincorporate exhaled $CO_2$ and restore normal arterial arterial chemistry (note: paper bag rebreathing is contraindicated in asthma or acute cardiac disease).

• Hypoxia:

  • Definition: Inadequate oxygen delivery or utilization at the cellular and tissue level throughout the body.

  • Causes: Decreased inspired oxygen concentration, airway obstruction, hypoventilation, impaired alveolar diffusion (pneumonia), impaired perfusion/transport (shock, heart failure), or severe anemia/carbon monoxide poisoning.

  • Clinical Manifestations (Early vs. Late):

    • Early Signs (Compensatory Phase): Apprehension, restlessness, irritability, anxiety, altered mental status/confusion, tachypnea, tachycardia, elevated blood pressure, dyspnea, pale cool skin, nasal flaring, and intercostal/substernal retractions.

    • Late Signs (Decompensation Phase): Central cyanosis (bluish discoloration of lips, tongue, mucous membranes, and facial skin), severe confusion, lethargy, stupor, bradypnea, bradycardia, hypotension, cardiac dysrhythmias, and coma.

    • Chronic Hypoxia Sign: Clubbing of the fingertips and toes (bulbous enlargement of distal phalanges with loss of the normal angle between nail plate and proximal nail fold), commonly seen in chronic conditions like COPD.

Alterations in Cardiac Functioning

• Disturbances in Conduction: Disruptions in electrical impulse generation or transmission alter mechanical cardiac output and systemic tissue perfusion.

  • Atrial Fibrillation (A-fib): Rapid, uncoordinated atrial quivering without effective atrial systole; leads to blood stasis in atria, dramatically increasing the risk of thrombus formation and systemic thromboembolism.

  • Supraventricular Tachycardia (SVT): Extremely rapid heart rate originating above the ventricles, shortening diastolic filling time and reducing cardiac output.

  • Ventricular Tachycardia (V-tach) & Ventricular Fibrillation (V-fib): Lethal ventricular dysrhythmias. In V-tach, rapid ventricular firing impairs filling; in V-fib, chaotic quivering eliminates cardiac output, resulting in immediate pulselessness and cardiac arrest.

• Altered Cardiac Output:

  • Left-Sided Heart Failure: Failure of left ventricular pumping capacity leads to backpressure into pulmonary veins, causing pulmonary congestion, pulmonary edema, crackles, dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.

  • Right-Sided Heart Failure: Failure of right ventricular pumping leads to systemic venous congestion, manifesting as dependent peripheral edema, hepatomegaly, splenomegaly, ascites, and Jugular Vein Distention (JVD).

• Impaired Valvular Function:

  • Stenosis: Hardening, calcification, or narrowing of heart valves restricts forward blood flow, increasing cardiac workload.

  • Regurgitation: Incompetent closure of heart valves allows backward leakage of blood into preceding chambers; most frequently affects aortic and mitral valves, producing audible cardiac murmurs.

• Myocardial Ischemia:

  • Mechanism: Inadequate coronary blood supply relative to myocardial oxygen demand.

  • Angina Pectoris: Transient, reversible chest pain or pressure secondary to temporary myocardial ischemia.

  • Myocardial Infarction (MI) / Acute Coronary Syndrome (ACS): Complete arterial occlusion resulting in irreversible myocardial cellular necrosis and tissue death.

Developmental, Lifestyle, and Environmental Factors

• Developmental Factors:

  • Infants & Toddlers: Small, narrow airway structures easily obstructed by mucus, edema, or aspirated foreign objects; immature immune systems make them susceptible to severe upper and lower respiratory tract infections (RSV, Croup).

  • School-Age Children & Adolescents: High exposure to communicable viral respiratory pathogens in group settings; active sports participation increases baseline oxygen consumption; emergence of asthma; potential initiation of tobacco, vaping, or substance use.

  • Young & Middle-Aged Adults: Unhealthy lifestyle habits (poor diet, physical inactivity, smoking), exposure to occupational dusts and chemical toxins, intense physical stress, and increased oxygen demands during pregnancy.

  • Older Adults: Age-related loss of pulmonary elastic recoil, weakening of respiratory intercostal and diaphragmatic muscles, stiffening of chest wall, reduced cough reflex effectiveness leading to impaired clearance of secretions, diminished immune function, and high prevalence of chronic diseases (COPD, Heart Failure, Diabetes).

• Lifestyle Factors:

  • Smoking: Primary cause of direct alveolar destruction, bronchial mucosal inflammation, cilia paralysis, and lung cancer.

  • Nutrition: Severe malnutrition leads to respiratory muscle atrophy; obesity mechanically impedes chest wall expansion.

  • Hydration: Dehydration hardens respiratory mucus, impeding ciliary clearing.

  • Substance Abuse & Alcohol: CNS depressants suppress brainstem respiratory centers, increasing aspiration risks.

  • Stress & Anxiety: Triggers hyperventilation, bronchospasm, and excessive cardiac metabolic demands.

• Environmental Factors:

  • Air Pollution & Smog: Irritates airway mucosa, precipitating asthma attacks and COPD exacerbations.

  • High Altitudes: Lower barometric pressure reduces partial pressure of inspired oxygen ($PiO_2$), inducing systemic hypoxemia.

  • Occupational Toxin Exposures: Inhalation of coal dust, silica, asbestos, industrial fumes, or chemical solvents.

  • Secondhand Smoke: Involuntary inhalation of tobacco smoke damages respiratory tissue, especially in infants and young children.

Comprehensive Nursing Assessment and Diagnostics

• Health History & Subjective Assessment:

  • Respiration Patterns: Baseline respiratory frequency, depth, ease, and recent changes.

  • Cough & Sputum: Presence of cough, timing, triggers, and characterization of sputum using the COCA acronym:

    • C - Color (clear, yellow, green, rust, hemoptysis)

    • O - Odor (foul-smelling indicates infection)

    • C - Consistency (tenacious, thick, thin, frothy)

    • A - Amount (scant, moderate, copious)

  • Chest Pain: Pleuritic (worsened by deep inspiration/coughing) vs. Cardiac pain.

  • Dyspnea: Onset, severity, aggravating/alleviating factors, orthopnea (number of pillows needed to sleep).

  • Other Parameters: History of fever, fatigue, smoking history (pack-years), environmental exposures, known allergies, and current medications (opiates, sedatives, bronchodilators).

• Physical Examination Methods:

  • Inspection: Respiratory rate, rhythm, depth, chest symmetry, retractions, accessory muscle use, position of comfort (tripod position), facial expression, skin color, and nail bed shape.

  • Palpation: Thoracic expansion symmetry, tactile fremitus, tenderness, tracheal alignment, and peripheral pulses.

  • Percussion: Resonant (normal lung), hyperresonant (trapped air in emphysema/pneumothorax), or dull (consolidation in pneumonia/pleural effusion).

  • Auscultation: Systematic listening over anterior, lateral, and posterior lung fields.

• Adventitious Breath Sounds:

  • Crackles (Rales): Discontinuous, high or low-pitched popping sounds heard primarily during inspiration; caused by air popping open fluid-filled or collapsed alveoli; cannot be cleared with a cough. Associated with pneumonia, pulmonary edema, CHF, and atelectasis.

  • Wheezes: Continuous, high-pitched, musical sound produced by high-velocity airflow through narrowed, constricted lower airways; heard during inspiration or expiration. Associated with acute asthma and bronchitis.

  • Rhonchi: Sonorous wheezes; deep, low-pitched, rumbling or snore-like sounds heard primarily during expiration; caused by thick mucus secretions or muscle spasms in large, central airways; can be cleared or altered by effective coughing.

  • Stridor: Harsh, high-pitched, vibrating acoustic sound heard primarily during inspiration; caused by critical, life-threatening upper airway obstruction of the larynx or trachea (e.g., Croup, epiglottitis, foreign body aspiration, chemical inhalation).

  • Pleural Friction Rub: Dry, raspy, grating, or leathery rubbing sound heard at the lung bases; caused by inflamed pleural membranes rubbing directly against each other (e.g., pleurisy).

• Physical Manifestations Table of Altered Oxygenation:

• Diagnostic Procedures & Blood Studies:

  • Pulse Oximetry ($SpO_2$): Non-invasive photoelectric sensor measuring hemoglobin oxygen saturation. Normal range is $95\%\text{--}100\%$. Note: Severe vasoconstriction, hypothermia, low cardiac output, carbon monoxide poisoning, or dark nail polish alter accuracy.

  • Chest X-Ray: Radiographic evaluation of thoracic structures to detect pneumonia, atelectasis, pneumothorax, or cardiomegaly.

  • Bronchoscopy: Direct endoscopic visualization of the larynx, trachea, and bronchi using a flexible fiberoptic scope to collect fluid/sputum samples, perform biopsies, or clear mucus plugs/foreign objects.

  • Pulmonary Function Tests (PFTs): Quantitative measurements of lung volumes, capacities, and flow rates to differentiate obstructive from restrictive pulmonary diseases.

  • Thoracentesis: Surgical needle perforation through the intercostal chest wall into the pleural cavity to aspirate pleural fluid for diagnostic analysis or therapeutic relief of pleural effusions.

  • Sputum Specimen: Expectorated, suctioned, or bronchoscopically obtained sputum for Gram stain, culture, and sensitivity to identify infectious pathogens.

  • Cardiopulmonary Blood Tests: Complete Blood Count ($CBC$ for hemoglobin and red cell indices), Cardiac Enzymes and Troponins (markers of myocardial necrosis), Serum Electrolytes, Fasting Lipid Profile, Brain Natriuretic Peptide ($BNP$—elevated in heart failure), and C-Reactive Protein ($CRP$—inflammatory marker).

Nursing Measures and Therapeutic Interventions

• Airway Maintenance & Respiratory Promotion:

  • Patent Airway: Regularly inspect airways for obstructions, assess cough efficiency, and utilize targeted suctioning when secretions block air passages.

  • Optimal Positioning: Place patients in semi-Fowler's or high-Fowler's position to lower abdominal organs away from the diaphragm, maximizing thoracic expansion.

    • Unilateral Lung Disease: Position patient with the "good lung down" (unaffected lung in dependent position) to enhance gravity-dependent perfusion and drainage of the affected upper lung.

    • Prone Positioning: Placing severe ARDS (Acute Respiratory Distress Syndrome) patients face-down on their abdomen recruits posterior lung alveoli and improves ventilation-perfusion ($V/Q$) matching.

    • Tripod Positioning: Chronically hypoxic COPD patients lean forward resting arms on a table to fix shoulder girdle muscles, assisting accessory chest expansion.

  • Deep Breathing & Coughing: Coach patients to perform deep diaphragmatic breaths followed by low-abdominal coughing to open collapsed alveoli and clear bronchial secretions.

  • Hydration: Ensure adequate oral or IV fluid intake ($1.5\text{--}2.5\,\text{L/day}$ unless contraindicated) to liquefy and thin thick respiratory secretions, enabling easier expectoration.

  • Humidification & Nebulization: Add sterile water humidifiers to oxygen delivery setups (especially for flow rates $> 2\text{--}4\,\text{L/min}$) to prevent mucosal drying, mucosal tearing, and nosebleeds. Administer aerosolized nebulizer treatments to deliver bronchodilators or mucolytics directly into bronchial trees.

  • Mobility & Early Ambulation: Encourage frequent position changes every 2 hours and early post-operative ambulation to expand lower lung lobes and mobilize pooled secretions. Perform passive or active Range of Motion (ROM) exercises for bedbound patients.

• Chest Physiotherapy (CPT) & Postural Drainage:

  • Chest Percussion: Rhythmically striking the chest wall over affected lung lobes using cupped hands or mechanical percussive vests (e.g., blue vibratory vest) to generate acoustic shockwaves that dislodge sticky bronchial secretions.

    • Contraindications to CPT: Chest trauma, flail chest, fractured ribs/sternum, severe osteoporosis, pulmonary embolism ($PE$), bleeding disorders, anticoagulant therapy, lung/chest tumors, pneumothorax, and severe thoracic pain.

  • Postural Drainage: Utilizing gravity-assisted body positions (e.g., Trendelenburg position—head down—for lower lobes; side-lying, prone) to drain secretions from specific lung segments into central airways for coughing or suctioning. Maintain each position for $10\text{--}15\,\text{minutes}$, often combined with percussion. Requires a specific healthcare provider order.

Advanced Airway Management and Artificial Ventilation

• Oxygen Delivery Devices:

  • Nasal Cannula:

    • Most common, simple, and inexpensive low-flow oxygen device.

    • Delivers oxygen concentrations ($FiO_2$) ranging from $24\%\text{--}44\%$ at flow rates between $1\text{--}6\,\text{L/min}$.

    • Does not impede talking or eating.

    • Flow Limit: Flow rates above $4\,\text{L/min}$ dry out nasal mucosa (requiring humidification) and cause swallowed air without substantially increasing delivered $FiO_2$.

    • High-Flow Nasal Cannula: Specialized thick green tubing setups capable of delivering heated, humidified oxygen flows up to $15\text{--}60\,\text{L/min}$.

  • Face Tent:

    • Loose, open-fitting shield covering nose and mouth; ideal for patients unable to tolerate tight-fitting masks due to facial trauma, burns, or severe claustrophobia.

    • Delivers $FiO_2$ between $30\%\text{--}50\%$ at flow rates of $4\text{--}8\,\text{L/min}$.

    • Nursing Consideration: Frequently monitor facial skin for dampness and moisture accumulation to prevent moisture-associated skin damage (MASD).

• Artificial Airways:

  • Oropharyngeal Airway: C-shaped curved plastic airway inserted through the mouth into the posterior pharynx to depress the tongue, maintaining airway patency in unconscious patients only (triggers severe gag reflex, vomiting, and laryngospasm in conscious patients).

  • Endotracheal (ET) Tube: Flexible tube inserted through mouth or nose past vocal cords directly into trachea for short-term emergency mechanical ventilation. Placement confirmation requires bilateral lung auscultation and an immediate chest X-ray.

  • Tracheostomy Tube: Surgical opening directly into the anterior trachea through the neck for long-term mechanical ventilation or airway protection (considered when intubation exceeds approximately 2 weeks).

• Mechanical Ventilation:

  • Invasive Mechanical Ventilation: Positive pressure breathing support delivered via ET tube or tracheostomy.

  • Non-Invasive Positive-Pressure Ventilation (NIV): Positive airway pressure supplied via tight-fitting facial or nasal masks without invasive intubation.

    • CPAP (Continuous Positive Airway Pressure): Delivers a continuous, constant level of positive pressure throughout both inspiration and expiration to hold collapsed airways open; commonly used for obstructive sleep apnea.

    • BiPAP (Bilevel Positive Airway Pressure): Delivers two distinct pressure levels—a higher pressure during inspiration (IPAP) to assist air entry, and a lower pressure during expiration (EPAP) to maintain alveolar expansion. Used for COPD exacerbations, CHF, and acute pulmonary edema.

    • Nursing Priorities for NIV: Inspect skin under tight mask straps for pressure injury development (apply protective Mepilex foam dressings over bridge of nose); maintain oral hygiene; ensure patient is alert enough to remove mask if vomiting occurs (to prevent lethal pulmonary aspiration); ensure patients with restraints have a dedicated sitter; remove patient's dentures prior to mask application.

• Chest Tubes: Catheters surgically placed into the intrapleural space to evacuate trapped air (pneumothorax), blood (hemothorax), or fluid (pleural effusion), re-establishing negative intrapleural pressure and re-expanding collapsed lungs.

Complications and Safety Precautions of Oxygen Therapy

• Complications of Oxygen Therapy:

  • Oxygen-Induced Hypoventilation: Blunting of the hypoxic respiratory drive in chronic hypercapnic COPD patients caused by high-dose oxygen therapy, leading to respiratory arrest and $CO_2$ narcosis.

  • Oxygen Toxicity: Inflammatory damage to alveolar-capillary membranes and surfactant loss caused by prolonged exposure to high concentrations of oxygen ($> 50\%$ for longer than $24\text{--}48\,\text{hours}$).

    • Symptom Mnemonic - VENT IDC:

      • V - Vision changes / central blind spots

      • E - Ear ringing / tinnitus

      • N - Nausea

      • T - Twitching of facial/hand muscles

      • I - Irritability and mood changes

      • D - Dizziness and lightheadedness

      • C - Convulsions / generalized seizures

  • Absorption Atelectasis: High inhaled oxygen fractions wash out nitrogen from alveoli. When the oxygen rapidly diffuses into pulmonary capillaries, the absence of inert nitrogen causes complete alveolar collapse.

  • Mucosal Drying & Skin Breakdown: Unhumidified dry gas causes mucosal inflammation, epistaxis (nosebleeds), and pressure necrosis on skin behind ears, over cheeks, and under nares.

• Oxygen Safety Rules & Precautions:

  • Combustion Hazard: Oxygen vigorously supports combustion; strictly prohibit open flames, lighted candles, gas stoves, space heaters, and smoking anywhere near oxygen equipment. Post explicit "No Smoking - Oxygen in Use" warning signs on doors.

  • Electrical & Static Safety: Avoid clothing made of synthetic fabrics that generate static electricity sparks; use only natural cotton fabrics. Inspect all electrical equipment in the room (razors, radios, suction pumps) for proper grounding.

  • Flammable Substances & Lubricants: Absolutely prohibit petroleum-based products (e.g., Vaseline, Carmex, petroleum jelly, oils, nail polish remover) on or around the face/nasal cannula due to high flammability risks under pure oxygen streams. Use strictly water-based lubricants (e.g., KY jelly, hospital-issued water-based lip balms) for nasal dryness.

  • Equipment Location: Ensure immediate knowledge of the emergency oxygen shut-off valve locations on the nursing unit.

Respiratory Pharmacology

• Bronchodilators: Fundamental therapeutic medications that relax bronchial smooth muscle, widening airway lumens and improving expiratory flow. Divided into three main classes: Beta-Adrenergic Agonists, Anticholinergics, and Xanthine Derivatives.

• Short-Acting Beta-2 Agonists (SABA):

  • Albuterol (Proventil):

    • Mechanism: Specific selective agonist of beta-2 adrenergic receptors in bronchial smooth muscle, causing rapid relaxation and bronchodilation during acute asthma attacks or bronchospasm.

    • Adult Dosages: Metered-Dose Inhaler (MDI): 2 puffs 4 times daily ($QID$); Nebulizer: $2.5\,\text{mg}$ 3 to 4 times daily; Oral tablets available.

    • Side Effects: Nervousness, muscular restlessness, tremor, headache, insomnia, chest pain, angina, tachycardia, palpitations, hypertension, hypokalemia, and hyperglycemia.

    • Nursing Implications: Auscultate lung sounds before and after administration; instruct patient to wait at least $1\,\text{minute}$ between inhaled puffs.

• Long-Acting Beta-2 Agonists (LABA):

  • Salmeterol (Serevent Diskus):

    • Mechanism: Long-acting beta-2 agonist for maintenance bronchodilation.

    • Adult Dosage: 1 puff twice daily.

    • Critical Warning: NEVER use Salmeterol for acute emergency treatment of asthma attacks. Used exclusively for chronic maintenance of asthma and COPD, always in combination with an inhaled corticosteroid.

• Vasoactive Catecholamines:

  • Epinephrine (Adrenalin):

    • Mechanism: Endogenous catecholamine acting directly on alpha-1, beta-1, and beta-2 adrenergic receptors of the sympathetic nervous system.

    • Indications: Emergency ACLS protocols, severe acute asthma, and systemic anaphylactic shock. Provides immediate, powerful bronchodilation via lung beta-2 receptors.

• Corticosteroids:

  • Mechanism: Potent anti-inflammatory and immunosuppressant agents that decrease mucosal edema, reduce vascular permeability, and inhibit inflammatory cytokine release.

  • Contraindications: Hypersensitivity, systemic fungal infections, and active bacterial infections (risk of precipitating steroid psychosis or immunosuppressive disease spread).

  • Abrupt Withdrawal Warning: Long-term systemic corticosteroid therapy suppresses the hypothalamic-pituitary-adrenal ($HPA$) axis and halts endogenous adrenal cortisol production. Therapy must NEVER be stopped abruptly; daily doses must be slowly tapered to prevent life-threatening hypo-adrenal crisis (adrenal insufficiency characterized by severe hypotension, circulatory collapse, and shock).

  • Prednisone: Primary oral corticosteroid used for anti-inflammatory maintenance and acute exacerbations of chronic respiratory illness.

  • Methylprednisolone (Solu-Medrol): Primary injectable IV glucocorticoid for acute severe respiratory inflammation. Pediatric Caution: Formulations containing benzyl alcohol preservative cannot be administered to neonates or infants under $28\,\text{days}$ of age.

• Expectorants:

  • Guaifenesin (Mucinex):

    • Mechanism: Increases fluid flow within the respiratory tract, reducing mucus viscosity and facilitating secretion clearance via coughing. Used for productive coughs from colds, bronchitis, pertussis, and influenza.

    • Clinical Hydration Note: Recent evidence indicates that oral guaifenesin has no greater therapeutic efficacy in thinning bronchial secretions than maintaining robust systemic fluid hydration with water.